233 results
8-K
EX-1.1
CTIC
CTI BioPharma Corp
6 Apr 21
Entry into a Material Definitive Agreement
4:02pm
or any court, domestic or foreign, relating to the use, production, disposal or release of hazardous or toxic substances or relating … to the protection or restoration of the environment or human exposure to hazardous or toxic substances (collectively, “environmental laws”), owns or operates any real
8-K
EX-1.1
h9o4x5e 5acaa2zx6r
15 Jan 21
Entry into a Material Definitive Agreement
5:27pm
8-K
EX-1.1
k9a0n
15 Nov 19
Entry into a Material Definitive Agreement
4:15pm
8-K
EX-1.1
sgfj2r15gz
1 Nov 18
Entry into a Material Definitive Agreement
4:29pm
8-K
EX-99.1
ntsihnpigax2b
13 Jan 15
Results of Operations and Financial Condition
12:00am
8-K
EX-99.1
bnf r1e94
9 Dec 14
CTI BioPharma Announces Comprehensive Kinome Analysis that Demonstrates
12:00am
424B2
gelhb9lax10u2vu6euk
6 Nov 14
Prospectus for primary offering
12:00am
8-K
EX-99.1
mxz 95w07y4khb8o
16 Sep 14
This presentation includes forward-looking statements within the meaning of the Safe Harbor provisions of the Private
12:00am
8-K
EX-99.1
21dvcemw4a szif
1 Jul 14
CTI BioPharma Completes Recruitment in PERSIST-1 Pivotal Phase 3 Trial of Pacritinib for Patients with Myelofibrosis
12:00am